These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 12369270
1. Dependence potential of antidepressants compared to benzodiazepines. van Broekhoven F, Kan CC, Zitman FG. Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jun; 26(5):939-43. PubMed ID: 12369270 [Abstract] [Full Text] [Related]
3. Cross-validation of the benzodiazepine dependence self-report questionnaire in outpatient benzodiazepine users. Kan CC, Breteler MH, van der Ven AH, Zitman FG. Compr Psychiatry; 2001 Jun; 42(5):433-9. PubMed ID: 11559871 [Abstract] [Full Text] [Related]
5. High prevalence of benzodiazepine dependence in out-patient users, based on the DSM-III-R and ICD-10 criteria. Kan CC, Breteler MH, Zitman FG. Acta Psychiatr Scand; 1997 Aug; 96(2):85-93. PubMed ID: 9272191 [Abstract] [Full Text] [Related]
6. Assessment of benzodiazepine dependence in alcohol and drug dependent outpatients: a research report. Kan CC, Breteler MH, van der Ven AH, Timmermans MA, Zitman FG. Subst Use Misuse; 2001 Jun; 36(8):1085-109. PubMed ID: 11504154 [Abstract] [Full Text] [Related]
8. An evaluation of DSM-III-R and ICD-10 benzodiazepine dependence criteria using Rasch modelling. Kan CC, Breteler MH, van der Ven AH, Zitman FG. Addiction; 1998 Mar; 93(3):349-59. PubMed ID: 10328043 [Abstract] [Full Text] [Related]
9. Latent trait standardization of the benzodiazepine dependence self-report questionnaire using the Rasch scaling model. Kan CC, van der Ven AH, Breteler MH, Zitman FG. Compr Psychiatry; 2001 Mar; 42(5):424-32. PubMed ID: 11559870 [Abstract] [Full Text] [Related]
16. Benzodiazepine dependence in Singapore. Dong Y, Winslow M, Chan YH, Subramaniam M, Whelan G. Subst Use Misuse; 2007 Mar; 42(8):1345-52. PubMed ID: 17674238 [Abstract] [Full Text] [Related]
18. Prevalence of and factors associated with acute withdrawal symptoms after 24 weeks of eszopiclone treatment in patients with chronic insomnia: a prospective, interventional study. Inoue Y, Takaesu Y, Koebis M. BMC Psychiatry; 2021 Apr 14; 21(1):193. PubMed ID: 33853571 [Abstract] [Full Text] [Related]